Prophylactic heparin in palliative care: A cautious welcome…

BMJ

Volumn 332, Issue 7543, 2006, Pages 728-729

  Pace, Victor ^a   Hal, Emma ^a   Bailey, Catherine ^a  

^a ST CHRISTOPHER S HOSPICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

HOSPICE CARE; HUMAN; METHODOLOGY; NEOPLASM; NOTE; PALLIATIVE THERAPY; PATIENT SATISFACTION; CANCER; CANCER RISK; DISEASE COURSE; EMBOLISM; HEALTH SURVEY; LETTER; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE;

ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPICE CARE; HUMANS; NEOPLASMS; PALLIATIVE CARE; PATIENT SATISFACTION;

EID: 33645507996     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.332.7543.728-b     Document Type: Letter

References (1)

1. Noble SIR, Nelson A, Turner C, Finlay IG. Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study. BMJ 2006; 332: 577–80. (11 March.)